Rx Ave Health
“Who handles pharmacy and prescription fulfillment? Rx Ave Health: [email], (833) 360-4276”
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: people who want posted prices for compounded semaglutide, tirzepatide or microdosing before an intake
BioPivot scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $168 a month; its compounded semaglutide, at $218, is 10% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Charged on top
Coaching
Not stated
Prices checked November 2026
BioPivot is a Phoenix telehealth brand that sells compounded semaglutide and tirzepatide, including lower-dose microdosing plans, plus sermorelin, NAD+, glutathione and PT-141. Elite Care Health, an independent physician group, prescribes, and Rx Ave Health fills the prescriptions. Monthly plans run $185 to $225 for semaglutide and $242 to $350 for tirzepatide, with microdosing from $168, and every plan price is posted before you start.
Yes. BioPivot is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.2/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
We know of no promo or coupon code for BioPivot. Its listed price is $168 a month. Coupon sites advertising "BioPivot discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how BioPivot compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Six columns, each one computed from something BioPivot has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
$218/month is 10% above the $199 median for compounded semaglutide across the sellers we compare. A cheaper starter or microdose price is also listed; Value is scored on the standard dose.
Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
A price is shown before the questionnaire starts.
It names the pharmacy that fills its prescriptions. It shows a price before asking for health information.
No state list is available to check, so this is held at the midpoint rather than scored on reach.
The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
Taken from the terms BioPivot publishes. Terms change, so check the current policy before you subscribe.
BioPivot lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
BioPivot sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Prices re-verified
Quarterly option listed at $400 (about $133/mo); whether that is one charge was not confirmed because the cart was not reached. Code BIOPIVOT20 takes 20% off the first order.
Quarterly option listed at $490 (about $163/mo).
Quarterly option listed at $518 (about $173/mo).
Quarterly option listed at $370 (about $123/mo). Sold as the GLP-1 Microdose program, 500 mcg/mL.
Quarterly option listed at $590 (about $197/mo); whether that is one charge was not confirmed. Code BIOPIVOT20 takes 20% off the first order.
Quarterly option listed at $780 (about $260/mo).
Quarterly option listed at $900 ($300/mo).
Quarterly option listed at $528 (about $176/mo).
Check the price yourself before you pay
Every figure here comes from BioPivot's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
BioPivot names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.
“Who handles pharmacy and prescription fulfillment? Rx Ave Health: [email], (833) 360-4276”
The standing price at BioPivot is $168/month.
For compounded semaglutide, the median across the sellers we compare is $199/month, so BioPivot's $218 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare BioPivot's cancellation terms with other sellers' cancellation and refund policies.
HealthRX dispenses semaglutide and tirzepatide from $165/month, which makes it the fair comparison to run before you commit here.
BioPivot prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. BioPivot also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
BioPivot tells you its price before you start the medical questionnaire and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to BioPivot. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against BioPivot. How we weigh oversight, disclosure and price is set out in our scoring methodology.
BioPivot also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
BioPivot lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. MEDGm is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
BioPivot scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $168 a month; its compounded semaglutide, at $218, is 10% above the $199 median among the sellers we compare.
Starting at $168 a month. Check today's price, then start the intake.
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
If none of these fits, our guide to alternatives to BioPivot sets more sellers in the same category beside BioPivot on price, states and what the price includes.
The words sellers use, defined. Tap any term.
Cited across this BioPivot review: primary regulatory filings, and peer-reviewed studies.
Plans start at $168 a month. Whether you qualify is a clinician's decision, made after your intake.